Industry News

25 August 2025

Eris Lifesciences receives Brazilian approval at its Ahmedabad facility

Eris Lifesciences announced that a manufacturing unit in its Ahmedabad campus has received approval from ANVISA, which is Brazil’s national health regulatory agency.

22 August 2025

A potential way to relieve arthritic knees without drugs or surgery

Nearly a quarter of people over the age of 40 experience painful osteoarthritis, making it a leading cause of disability in adults. Osteoarthritis degrades joint-cushioning cartilage, and there is currently no way of reversing this damage: the only option is to manage pain with medication, and eventually, joint replacement.

22 August 2025

Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer, one of the most aggressive and hard-to-treat forms of breast cancer.

19 August 2025

Vanda won Federal appeal to overturn FDA Denying Approval of Hetlioz

Vanda Pharmaceuticals Inc. (Vanda) announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its longstanding dispute with the agency regarding the approvability of HETLIOZ® (tasimelteon) to treat jet lag disorder

15 August 2025

Lilly launches Mounjaro Kwikpen in India at Rs 14,000

Eli Lilly has launched its easy-to-use Mounjaro Kwikpen in India, with the starting dose of 2.5 mg priced at Rs.14,000 (around USD 160) for a months supply, Reuters reported.

14 August 2025

Apertura Gene Therapy Licenses Blood-Brain Barrier-Penetrant AAV Capsid to Multiple Partners Advancing Central Nervous System Treatments

Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions announced several licensing deals with Galibra Neuroscience and Emugen Therapeutics to utilize Apertura’s human transferrin receptor 1 capsid (TfR1 CapX) for their central nervous system (CNS) programs. A third venture-backed biotechnology company has entered into an Option Agreement with Apertura for multiple CNS indications.

14 August 2025

AAVantgarde Bio announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

AAVantgarde Bio a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation for AAVB-039, the companys gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4

13 August 2025

Anixa Biosciences secures New U.S. Patent extending CAR-T Cancer Therapy Protection to 2045

Anixa Biosciences, Inc., a clinical-stage biotechnology company specializing in cancer treatment and prevention, has announced the issuance of a new U.S. patent for its chimeric antigen receptor-T cell (CAR-T) technology.

13 August 2025

Zydus Lifesciences delivers steady growth in Q1 FY26, boosted by global expansion

Zydus Lifesciences Limited reported a steady performance for the quarter ended June 30, 2025, with growth across key geographies and strong contributions from innovation-driven initiatives. The pharmaceutical major posted revenue from operations of Rs. 65,737 million, marking a 6% increase year-on-year and a marginal 0.7% rise from the previous quarter. Net profit stood at Rs. 14,668 million, up 3% from the same quarter last year and a robust 25.3% higher than Q4 FY25.

13 August 2025

Indoco Remedies receives final ANDA approval from USFDA for Rivaroxaban Tablets

Indoco Remedies Ltd. announced final approval of the Company Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg, to market a generic equivalent to the reference listed drug (RLD), Xarelto Tablets, 2.5 mg, 10 mg, 15 mg and 20 mg, of Janssen Pharmaceuticals, Inc. (Janssen), from USFDA.

Search

Eris Lifesciences receives Brazilian approval at its Ahmedabad facility

RECOMMENDED POSTS

Subscribe with us

Jobs by Category